Suven Pharmaceuticals Limited

Pharmaceuticals, Biotechnology and Life Sciences

Targets set1.5°CNet-Zero: Targets set

SBTI ID

40011955

Informations générales

Localisation

India

Asia

Secteur d'activité

Pharmaceuticals, Biotechnology and Life Sciences

Type d'organisation

Corporate

Dernière mise à jour

26/06/2025

Objectifs à court terme (Near-Term)
Engagement de réduction des émissions à horizon FY2033

Statut

Targets set

Classification

1.5°C

Année cible

FY2033

Progression vers l'objectif0%
2015 (année de référence)FY2033
Objectifs à long terme (Long-Term)
Engagement de réduction des émissions à horizon FY2050

Statut

Targets set

Classification

1.5°C

Année cible

FY2050

Progression vers l'objectif0%
2015 (année de référence)FY2050
Description complète des objectifs

Overall Net-Zero Target: Suven Pharmaceuticals Limited commits to reach net-zero greenhouse gas emissions across the value chain by FY2050. Near-Term Targets: Suven Pharmaceuticals Limited commits to reduce absolute scope 1 and 2 GHG emissions 54.6% by FY2033 from a FY2023 base year.* Suven Pharmaceuticals Limited also commits to reduce absolute scope 3 GHG emissions 54.6% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks. Long-Term Targets: Suven Pharmaceuticals Limited commits to reduce absolute scope 1 and 2 GHG emissions 90% by FY2050 from a FY2023 base year.* Suven Pharmaceuticals Limited also commits to reduce absolute scope 3 GHG emissions 90% within the same timeframe. *The target boundary includes land-related emissions and removals from bioenergy feedstocks.

Net-Zero

Statut

Targets set

Année cible

FY2050

Progression0%
Classification détaillée

The targets covering greenhouse gas emissions from company operations (scopes 1 and 2) are consistent with reductions required to keep warming to 1.5°C

Identifiants

LEI

335800QWT92US4D7HR32

Source : Science Based Targets initiative | Données publiques